[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342505-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-342505-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","identification-of-banf1-as-a-novel-prognostic-biomarker-in-gastric-cancer-and-validation-via-in-vitro-and-in-vivo-experiments","Identification of BANF1 as a novel prognostic biomarker in gastric cancer and validation via in-vitro and in-vivo experiments","","Gastric cancer (GC) is a prevalent malignancy with a poor prognosis. The study analyzed GC high-throughput sequencing data from GEO to identify characteristic genes associated with GC, highlighting barrier to autointegration factor 1 (BANF1) as highly expressed across cancer types and linked to prognosis. Bioinformatic results suggested BANF1 correlates with immune cell infiltration. In vitro assays confirmed BANF1 upregulation in GC tissues and cells, and BANF1 knockdown reduced proliferation, migration, and invasion. In vivo nude mouse experiments showed inhibited tumor growth after BANF1 knockdown.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-banf1-as-a-novel-prognostic-biomarker-in-gastric-cancer-and-validation-via-in-vitro-and-in-vivo-experiments/342505/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-banf1-as-a-novel-prognostic-biomarker-in-gastric-cancer-and-validation-via-in-vitro-and-in-vivo-experiments/342505.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What was the main goal of the study on BANF1 in gastric cancer?","Question",{"text":62,"@type":63},"To identify BANF1-related signals from transcriptome datasets and validate BANF1 as a prognostic biomarker and potential therapeutic target using in vitro and in vivo experiments.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How did the study identify BANF1 as a prognostic indicator?",{"text":67,"@type":63},"Bioinformatic analyses of GC high-throughput sequencing data from GEO highlighted BANF1’s association with patient prognosis and its relevance to immune cell infiltration.",{"name":69,"@type":60,"acceptedAnswer":70},"What effects did BANF1 knockdown have in GC models?",{"text":71,"@type":63},"In vitro, BANF1 knockdown attenuated GC cell proliferation, migration, and invasion. In vivo, BANF1 knockdown impeded tumor growth in nude mouse models.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},342505,1790131696,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 2  \nResearch Paper  \nIdentification of BANF1 as a novel prognostic biomarker in gastric cancer and validation via in-vitro and in-vivo experiments  \nYuanmin Xu1,*, Xu Wang1,*, Weiwei Yuan2, Ling Zhang3, Wei Chen1, Kongwang Hu1,4  \n1 Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China 2 Department of General Surgery, Anhui Public Health Clinical Center, Hefei 230032, China  \n3 Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China 4 Department of General Surgery, Fuyang Affiliated Hospital of Anhui Medical University, Fuyang 236000, China * Equal contribution  \nCorrespondence to: Wei Chen, Kongwang Hu; email: [chenwei366@ahmu.edu.cn](chenwei366@ahmu.edu.cn); [hukongwang69@163.com](hukongwang69@163.com), [https://orcid.org/0009-0007-4781-3948](https://orcid.org/0009-0007-4781-3948)  \nKeywords: gastric cancer, barrier to autointegration factor 1, overall survival, TCGA, GEO  \nReceived: September 18, 2023 Accepted: December 14, 2023 Published: January 22, 2024  \nCopyright: © 2024 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nGastric cancer (GC) is a widespread malignancy characterized by a notably high incidence rate and an unfavorable prognosis. We conducted a meticulous analysis of GC high-throughput sequencing data downloaded from the Gene Expression Omnibus (GEO) repository to pinpoint distinctive genes associated with GC. Our investigation successfully identified three signature genes implicated in GC, with a specific focus on the barrier to autointegration factor 1 (BANF1), which exhibits elevated expression across various cancer types, including GC. Bioinformatic analysis has highlighted BANF1 as a prognostic indicator for patients with GC, with direct implications for immune cell infiltration. To gain a more comprehensive understanding of the significance of BANF1 in GC, we performed a series of in vitro experiments to confirm its high expression in GC tissues and cellular components. Intriguingly, the induction of BANF1 knockdown resulted in a marked attenuation of proliferation, migratory capacity, and invasive potential in GC cells. Moreover, our in vivo experiments using nude mouse models revealed a notable impediment in tumor growth following BANF1 knockdown. These insights underscore the feasibility of BANF1 as a novel therapeutic target for GC.  \nINTRODUCTION  \nGC poses a significant global health challenge within the gastrointestinal tract. In 2020 alone, the global incidence of GC surpassed 1,089,103 cases, leading to the unfortunate demise of over 760,000 individuals [1] . Helicobacter pylori infection stands out as a major contributing factor to GC [2] . Diagnostic strategies, such as computed tomography, endoscopy, and histopathological examination, form the primary tools for GC detection. Surgical intervention remains pivotal for early-stage GC, while unresectable cases necessitate a multimodal approach combining symptomatic management, chemotherapy, and targeted therapies to  \nenhance both quality of life and survival periods [3, 4] . The intrinsic heterogeneity of GC, as classified by The Cancer Genome Atlas (TCGA) into four subtypes, poses a formidable challenge, emphasizing the need for personalized treatment strategies [5] . Molecular biology investigations utilizing high-throughput sequencing hold promise in uncovering novel therapeutic targets fora more effective GC treatment landscape.  \nBarrier to autointegration factor 1 (BANF1), predominantly situated in the inner nuclear membrane, plays a crucial role in fundamental biological processes [6] . In the context of DNA repair, BANF1 emerges as a central figure in resol","cbCaip3ul3GPx4Bf","https://ap.wps.com/l/cbCaip3ul3GPx4Bf","pdf",3387363,21,"English","# Abstract\n# Introduction\n# Results\n## Differentially expressed genes (DEGs) in GC","[{\"question\":\"What was the main goal of the study on BANF1 in gastric cancer?\",\"answer\":\"To identify BANF1-related signals from transcriptome datasets and validate BANF1 as a prognostic biomarker and potential therapeutic target using in vitro and in vivo experiments.\"},{\"question\":\"How did the study identify BANF1 as a prognostic indicator?\",\"answer\":\"Bioinformatic analyses of GC high-throughput sequencing data from GEO highlighted BANF1’s association with patient prognosis and its relevance to immune cell infiltration.\"},{\"question\":\"What effects did BANF1 knockdown have in GC models?\",\"answer\":\"In vitro, BANF1 knockdown attenuated GC cell proliferation, migration, and invasion. In vivo, BANF1 knockdown impeded tumor growth in nude mouse models.\"}]","Identification of BANF1 as a novel prognostic biomarker in gastric cancer and validation via in-vitro and in-vivo experiments | PDF",1790046876,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d7632dd33be1fcf9f4527cc425b20a3.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f6f0b139e6b2f7528ce6d00b7212304.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a84bd51bb955551e443c384621f5b6b.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60c186b4f7923aefadf8e32d8b11462d.webp",980,1268]